Pneumonia Vaccine

Vaccination discrepancies among older demographic groups are likely due to care access, hesitancy and cost, the AARP says.

Older adults who are not up-to-date on their pneumococcal vaccine are unlikely to accept the shot after admission to a nursing facility, a study of pre-pandemic vaccinations finds.

The CDC has published revised recommendations for pneumococcal vaccination in the elderly and immunocompromised following a vote by its immunization advisors.

Study participants’ immune responses to the newly approved pneumonia vaccine and an adjuvanted flu drug were the same, whether the drugs were given together or a month apart, the drugmaker reports. And...

The two available pneumonia vaccines recommended for older adults are equally good at safeguarding the health of people with chronic obstructive pulmonary disease. But Prevnar13 appears to offer longer-term...

Drugmaker Merck is encouraging the use of its new shot, Vaxneuvance, in older adults diagnosed with certain chronic medical conditions or who are immunocompromised.

In total, 17.2 million adult vaccine doses were missed in 2020. And immunizations continue to lag well behind 2019 levels, reports GlaxoSmithKline.

Pfizer’s Prevnar 20 protects against microorganisms that cause more than half of the invasive pneumococcal disease cases found in seniors — including bacteremia and meningitis, the company says.

Trial participants — all aged 65 years and older — will be followed for six months to assess the safety of administering the two shots together and to track each vaccine’s effect on immunity,...

Routine vaccinations among older Medicare beneficiaries have not yet recovered from their pandemic slump. Stepped-up efforts to resolve the disruption are necessary, and may give clinicians a chance to...